BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21369712)

  • 41. Microneedles as transdermal delivery systems: combination with other enhancing strategies.
    Nava-Arzaluz MG; Calderon-Lojero I; Quintanar-Guerrero D; Villalobos-Garcia R; Ganem-Quintanar A
    Curr Drug Deliv; 2012 Jan; 9(1):57-73. PubMed ID: 21864254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteins and peptides: strategies for delivery to and across the skin.
    Benson HA; Namjoshi S
    J Pharm Sci; 2008 Sep; 97(9):3591-610. PubMed ID: 18200531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal delivery of tea catechins by electrically assisted methods.
    Fang JY; Hung CF; Hwang TL; Wong WW
    Skin Pharmacol Physiol; 2006; 19(1):28-37. PubMed ID: 16247247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of skin permeability with thermal ablation techniques: concept to commercial products.
    Parhi R; Mandru A
    Drug Deliv Transl Res; 2021 Jun; 11(3):817-841. PubMed ID: 32696221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin.
    Gratieri T; Alberti I; Lapteva M; Kalia YN
    Eur J Pharm Sci; 2013 Dec; 50(5):609-22. PubMed ID: 23567467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Theme section: transdermal delivery of proteins.
    Banga AK
    Pharm Res; 2007 Jul; 24(7):1357-9. PubMed ID: 17492493
    [No Abstract]   [Full Text] [Related]  

  • 47. Perspectives on Transdermal Electroporation.
    Ita K
    Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26999191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery.
    Herwadkar A; Banga AK
    Ther Deliv; 2012 Mar; 3(3):339-55. PubMed ID: 22833994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: a review.
    Han T; Das DB
    Eur J Pharm Biopharm; 2015 Jan; 89():312-28. PubMed ID: 25541440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis.
    Choi EH; Lee SH; Ahn SK; Hwang SM
    Skin Pharmacol Appl Skin Physiol; 1999; 12(6):326-35. PubMed ID: 10545829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal iontophoresis. Part II: Peptide and protein delivery.
    Pillai O; Nair V; Poduri R; Panchagnula R
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):229-40. PubMed ID: 10389126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent progress in transdermal sonophoresis.
    Ita K
    Pharm Dev Technol; 2017 Jun; 22(4):458-466. PubMed ID: 26608060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic and therapeutic applications of iontophoresis.
    Sieg A; Wascotte V
    J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing transdermal drug delivery with electroporation.
    Wong TW; Ko SF; Hui SW
    Recent Pat Drug Deliv Formul; 2008; 2(1):51-7. PubMed ID: 19075897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.
    Fang JY; Lee WR; Shen SC; Fang YP; Hu CH
    Br J Dermatol; 2004 Jul; 151(1):132-40. PubMed ID: 15270882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal delivery of naloxone hydrochloride using minimally invasive physical ablation techniques.
    Tijani AO; Dandekar AA; Karve T; Banga AK; Puri A
    Int J Pharm; 2023 Jul; 642():123159. PubMed ID: 37336303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advancements in transdermal drug delivery: A comprehensive review of physical penetration enhancement techniques.
    Gaikwad SS; Zanje AL; Somwanshi JD
    Int J Pharm; 2024 Mar; 652():123856. PubMed ID: 38281692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.